Organovo Holdings Inc ONVO:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
2.74quote price arrow down-0.21 (-7.12%)
Volume
27,934
52 week range
2.56 - 23.92
Loading...
  • Open3.01
  • Day High3.03
  • Day Low2.68
  • Prev Close2.95
  • 52 Week High23.92
  • 52 Week High Date02/11/21
  • 52 Week Low2.56
  • 52 Week Low Date01/24/22

Key Stats

  • Market Cap23.87M
  • Shares Out8.71M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.57
  • YTD % Change-24.52

KEY STATS

  • Open3.01
  • Day High3.03
  • Day Low2.68
  • Prev Close2.95
  • 52 Week High23.92
  • 52 Week High Date02/11/21
  • 52 Week Low2.56
  • 52 Week Low Date01/24/22
  • Market Cap23.87M
  • Shares Out8.71M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.57
  • YTD % Change-24.52

RATIOS/PROFITABILITY

  • EPS (TTM)-1.40
  • P/E (TTM)-1.96
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-11.061M
  • ROE (TTM)-41.13%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)95.64%
  • Net Margin (TTM)-5,977.18%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date02/08/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Organovo Holdings Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Organovo Holdings, Inc. is an early stage biotechnology company. The Company is focused on building high fidelity, three-dimensional (3D) tissues that recapitulate key aspects of human disease. The Company is targeting the intestine and has ongoing 3D tissue developments in Ulcerative colitis (UC) and Crohn's disease (CD). The Company uses its platform technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture...
Keith Murphy
Executive Chairman of the Board, Chief Executive Officer, Executive Director
Thomas Hess
President, Chief Financial Officer
Thomas Jurgensen J.D.
General Counsel, Corporate Secretary
Address
440 Stevens Avenue, Suite 200
Solana Beach, CA
92075
United States

Top Peers

SYMBOLLASTCHG%CHG
BLPH
Bellerophon Therapeutics Inc
2.18-0.18-7.63%
DFFN
Diffusion Pharmaceuticals Inc
0.2425-0.0124-4.8646%
TPST
Tempest Therapeutics Inc
3.58-0.18-4.79%
NDRA
ENDRA Life Sciences Inc
0.60-0.04-6.25%
NRBO
Neurobo Pharmaceuticals Inc
1.02-0.01-0.97%
FBRX
Forte Biosciences Inc
1.32-0.08-5.71%